Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours Β· Estimated delivery Aug 7 - Aug 12
In the landmark SURMOUNT-1 trial, participants achieved average weight reductions after 72 weeks of treatment of: approximately 15% with the 5 mg dose
Those with conditions such as diabetes and heart disease are much more likely to get full or partial coverage than those seeking to lose weight
This quiz is designed to be a fun, interactive way for you to learn about how GLP-1 medications work in managing type 2 diabetes
While either drug can be quite effective, a recent study has found that people taking Zepbound (tirzepatide) have had better results than people taking Wegovy (semaglutide)
Kelly AS, Auerbach P, Barrientos-Perez M, et al
Second, insulin resistance downregulates the mammalian Target of Rapamycin (mTOR) metabolic pathway, which is the major anabolic activation pathway in mammals [15]
